ArticleActa pharmaceutica Sinica. B2020

PCC0208017, a novel small-molecule inhibitor of MARK3/MARK4, suppresses glioma progression

Fangfang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.